Prosecution Insights
Last updated: April 19, 2026

Covington & Burling LLP

8 pending office actions • 4 clients

Portfolio Summary

8
Total Pending OAs
0
Final Rejections
8
Non-Final OAs

Client Portfolio (4 clients)

Client (Assignee)Pending OAs
Bristol-Myers Squibb Company 5
Scynexis, Inc. 1
Brooklyn Bridge To Cambodia, Inc. 1
Greening Be Gone, LLC 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19406929 Untitled Bristol-Myers Squibb Company RZECZYCKI, PHILLIP MATTHEW 1625 Non-Final OA
19406921 Untitled Bristol-Myers Squibb Company RZECZYCKI, PHILLIP MATTHEW 1625 Non-Final OA
18608350 INJECTABLE COMPOSITIONS OF TRITERPENOID ANTIFUNGALS ENCAPSULATED IN LIPOSOMES Scynexis, Inc. RONEY, CELESTE A 1612 Non-Final OA Mar 18, 2024
18684747 CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3- (1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3) PYRIDAZINE-3-CARBOXAMIDE Bristol-Myers Squibb Company CHANDRAKUMAR, NIZAL S 1625 Non-Final OA Feb 19, 2024
18284531 CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE Bristol-Myers Squibb Company CHAO, ALLEN 1622 Non-Final OA Sep 27, 2023
18276837 SINGLE OPERATOR SEED PLANTING APPARATUSES, SYSTEMS, AND METHODS OF USE Brooklyn Bridge To Cambodia, Inc. TORRES, ALICIA M 3671 Non-Final OA Aug 10, 2023
18026704 DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES Bristol-Myers Squibb Company WELLS, LAUREN QUINLAN 1622 Non-Final OA Mar 16, 2023
17627112 COMPOSITION AND METHOD OF TREATING BACTERIAL AND VIRAL PATHOGENS IN PLANTS Greening Be Gone, LLC SONG, JIANFENG 1613 Non-Final OA Jan 13, 2022

Managing Covington & Burling LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month